NCT02900066 (JOKA-II) is a clinical trial in Fever, sponsored by Institute of Tropical Medicine, Belgium.

Who is sponsoring NCT02900066?

NCT02900066 is sponsored by Institute of Tropical Medicine, Belgium.

Is NCT02900066 still recruiting?

NCT02900066 is currently completed. Last updated 3 March 2021.

Last reviewed 2021-03-03 · How we verify

NCT02900066: JOKA-II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Filter Paper Blood Spots Collected During Fever as a Source for Post-travel Diagnosis in Travelers

Completed Last updated 3 March 2021

What this trial tests

trial in Fever in 350 participants. Completed in 1 September 2018.

Timeline

1 February 2016

Primary endpoint
1 December 2017

1 September 2018

Quick facts

Lead sponsor	Institute of Tropical Medicine, Belgium
Status	Completed
Study type	OBSERVATIONAL
Enrollment	350
Start date	1 February 2016
Primary completion	1 December 2017
Estimated completion	1 September 2018
Sites	1 location across Belgium

Conditions studied

Fever — all drugs for Fever →

Sponsor

Institute of Tropical Medicine, Belgium

Who can join

18 and older, any sex, with Fever. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is part of a larger prospective cohort study (JOKA), designed to study febrile illness occurring during a travel to the tropics, as well as the evaluation of the clinical use of malaria rapid diagnostic tests (RDT) by travelers or their peers during travel, as a decision aid for the management of febrile illness in the tropics. Filter paper blood spots and paired serology are used in addition to routine post-travel evaluation, to study the incidence and etiological spectrum of febrile illness occurring during travel to the tropics. The study will yield valuable and prospective data of incidence rate, the clinical and etiological spectrum, clinical course and outcome of febrile illness during (and post-)travel in a prospective cohorts of travelers. This knowledge may lead to better pre-travel advice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fever

Currently open trials in the same condition.

NCT07432893 — Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts · NA · recruiting
NCT06447337 — Continuos Body Temperature Monitoring · recruiting
NCT07074912 — Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department · NA · recruiting
NCT06682416 — The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever · NA · recruiting
NCT06637904 — TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections · NA · recruiting

Other Institute of Tropical Medicine, Belgium trials

Trials by the same sponsor.

NCT07463040 — Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) · Phase 3 · not yet recruiting
NCT07174648 — Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo. · not yet recruiting
NCT07499739 — Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX) · Phase 4 · not yet recruiting
NCT07342829 — Prospective Follow-up After MVA-BN Booster Vaccination · not yet recruiting
NCT06839989 — An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02900066 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institute of Tropical Medicine, Belgium
Last refreshed: 3 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02900066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing